Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Sayuk

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Alimentary Pharmacology & Therapeutics|January 13, 2018
Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health AdministrationG S Sayuk, N Kanuri, C P Gyawali, et al.
Neurogastroenterology and Motility|May 7, 2016
The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS)N Kanuri, B Cassell, S E Bruce, et al.
Gastro Hep Advances|March 9, 2022
Colonoscopy Following COVID-19 Delays in Procedures: Risk Stratification for Procedures Is CriticalC D L Fritz, G S Sayuk, J E Elwing, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2016
Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndromeA Patel, S Hasak, B Cassell, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2013
Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of lifeV M Kushnir, B Cassell, C P Gyawali, et al.
Neurogastroenterology and Motility|April 1, 2015
A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndromeB Czogalla, S Schmitteckert, L A Houghton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Alimentary Pharmacology & Therapeutics|January 13, 2018
Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health AdministrationG S Sayuk, N Kanuri, C P Gyawali, et al.
Neurogastroenterology and Motility|May 7, 2016
The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS)N Kanuri, B Cassell, S E Bruce, et al.
Gastro Hep Advances|March 9, 2022
Colonoscopy Following COVID-19 Delays in Procedures: Risk Stratification for Procedures Is CriticalC D L Fritz, G S Sayuk, J E Elwing, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2016
Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndromeA Patel, S Hasak, B Cassell, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2013
Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of lifeV M Kushnir, B Cassell, C P Gyawali, et al.
Neurogastroenterology and Motility|April 1, 2015
A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndromeB Czogalla, S Schmitteckert, L A Houghton, et al.
Pageof 2